Chemical modification and irreversible inhibition of striatal A2a adenosine receptors

Mol Pharmacol. 1992 Jul;42(1):123-33.

Abstract

The ligand recognition site of A2a-adenosine receptors in rabbit striatal membranes was probed using non-site-directed labeling reagents and specific affinity labels. Exposure of membranes to diethylpyrocarbonate at a concentration of 2.5 mM, followed by washing, was found to inhibit the binding of [3H]CGS 21680 and [3H]xanthine amine congener to A2a receptors, by 86 and 30%, respectively. Protection from diethylpyrocarbonate inactivation by an adenosine receptor agonist, 5'-N-ethylcarboxamidoadenosine, and an antagonist, theophylline, suggested the presence of two histidyl residues on the receptor, one associated with agonist binding and the other with antagonist binding. Binding of [3H]CGS 21680 or [3H]xanthine amine congener was partially restored after incubation with 250 mM hydroxylamine, further supporting histidine as the modification site. Preincubation with disulfide-reactive reagents, dithiothreitol or sodium dithionite, at greater than 5 mM inhibited radioligand binding, indicating the presence of essential disulfide bridges in A2a receptors, whereas the concentration of mercaptoethanol required to inhibit binding was greater than 50 mM. A number of isothiocyanate-bearing affinity labels derived from the A2a-selective agonist 2-[(2-aminoethylamino) carbonylethylphenylethylamino]-5'-N- ethylcarboxamidoadenosine (APEC) were synthesized and found to inhibit A2a receptor binding in rabbit and bovine striatal membranes. Binding to rabbit A1 receptors was not inhibited. Preincubation with the affinity label 4-isothiocyanatophenylaminothiocarbonyl-APEC (100 nM) diminished the Bmax for [3H]CGS 21680 binding by 71%, and the Kd was unaffected, suggesting a direct modification of the ligand binding site. Reversal of 4-isothiocyanatophenylaminothiocarbonyl-APEC inhibition of [3H]CGS 21680 binding with hydroxylamine suggested that the site of modification by the isothiocyanate is a cysteine residue. A bromoacetyl derivative of APEC was ineffective as an affinity label at submicromolar concentrations.

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / metabolism
  • Adenosine / pharmacology
  • Adenosine-5'-(N-ethylcarboxamide)
  • Affinity Labels
  • Amino Acid Sequence
  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Diethyl Pyrocarbonate / pharmacology
  • Drug Antagonism
  • Hydroxylamine
  • Hydroxylamines / pharmacology
  • Molecular Sequence Data
  • Phenethylamines / metabolism
  • Purinergic Antagonists*
  • Rabbits
  • Radioligand Assay
  • Receptors, Purinergic / chemistry
  • Receptors, Purinergic / drug effects
  • Receptors, Purinergic / metabolism
  • Theophylline / pharmacology
  • Xanthines / metabolism

Substances

  • Affinity Labels
  • Hydroxylamines
  • Phenethylamines
  • Purinergic Antagonists
  • Receptors, Purinergic
  • Xanthines
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
  • Hydroxylamine
  • Adenosine-5'-(N-ethylcarboxamide)
  • 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine
  • Theophylline
  • Adenosine
  • Diethyl Pyrocarbonate